» Articles » PMID: 15922945

The 'danger' Sensors That STOP the Immune Response: the A2 Adenosine Receptors?

Overview
Journal Trends Immunol
Date 2005 Jun 1
PMID 15922945
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cells not only destroy pathogens but might also cause collateral injuries to normal tissues. The surprisingly low incidence of post-inflammatory complications is explained here by a 'danger-sensing' physiological mechanism that ensures the tissue-protecting negative feedback inhibition of overactive immune cells. We focus here on immunoregulatory influences of 'non-immune' signaling molecules in physiological and pathophysiological tissue microenvironments. We propose that hypoxia-associated accumulation of extracellular adenosine might be an important immunoregulatory signal. A2 receptors for extracellular adenosine might act as both primary sensors of excessive collateral tissue damage during an immune response and triggers of the emergency downregulation of overactive immune cells. Regulation by extracellular adenosine would protect normal organs from injury and/or re-direct immune responses.

Citing Articles

Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.

Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L Cells. 2024; 13(18.

PMID: 39329710 PMC: 11429654. DOI: 10.3390/cells13181526.


Regulatory T cell homing and activation is a signature of neonatal sepsis.

Sossou D, Ezinmegnon S, Agbota G, Gbedande K, Accrombessi M, Massougbodji A Front Immunol. 2024; 15:1420554.

PMID: 39072327 PMC: 11272980. DOI: 10.3389/fimmu.2024.1420554.


Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy.

Qin H, Teng Y, Dai R, Wang A, Liu J Front Immunol. 2024; 15:1395187.

PMID: 38799466 PMC: 11116596. DOI: 10.3389/fimmu.2024.1395187.


Metabolic instruction of the graft-versus-leukemia immunity.

Burk A, Apostolova P Front Immunol. 2024; 15:1347492.

PMID: 38500877 PMC: 10944922. DOI: 10.3389/fimmu.2024.1347492.


Prostaglandin E controls the metabolic adaptation of T cells to the intestinal microenvironment.

Villa M, Sanin D, Apostolova P, Corrado M, Kabat A, Cristinzio C Nat Commun. 2024; 15(1):451.

PMID: 38200005 PMC: 10781727. DOI: 10.1038/s41467-024-44689-2.